Deferasirox Impurity 22 | CAS 62327-30-4 - Request Quote
Deferasirox Impurity 22
| SZ CAT No: | SZ-D020038 |
| CAS No | 62327-30-4 |
| Mol.F. | C14H12N2O4 |
| Mol.Wt. | 272.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Deferasirox Impurity 22 is chemically 4,4'-(Hydrazine-1,2-diyl)dibenzoic acid. Deferasirox Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Deferasirox Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Deferasirox.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 62327-30-4
Purchase 62327-30-4
Order 62327-30-4
Enquire 62327-30-4
price of 62327-30-4
62327-30-4 Supplier
62327-30-4 Manufacturer
62327-30-4 Exporter
buy high quality Deferasirox Impurity 22
Purchase Deferasirox Impurity 22
Deferasirox Impurity 22 suppliers
Deferasirox Impurity 22 manufacturers
Deferasirox Impurity 22 price
Order Deferasirox Impurity 22
Enquire Deferasirox Impurity 22
Deferasirox Impurity 22 cost
Deferasirox Impurity 22 Supplier
Deferasirox Impurity 22 Distributor
Deferasirox Impurity 22 for Method Validation
Deferasirox Reference Standard
Deferasirox Impurity 22 for ANDA Filing
Deferasirox Impurity 22 for Forced Degradation Studies
Deferasirox Impurity 22 Identification Standards
Deferasirox Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.